<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
	<title>BioToday.com [新着ニュース]</title>
	<description>BioToday.comは医学情報、バイオテクノロジー、バイオベンチャー関連ニュースのデータベースです。</description>
	<link>http://www.biotoday.com/news.cfm</link>
	<managingEditor>biotoday@biotoday.com</managingEditor>
	<copyright>Copyright &#169; 2026 BioToday Ltd. All Rights Reserved.</copyright>
	<lastBuildDate>Thu, 17 Sep 2026 16:44:51 +0900</lastBuildDate>
	<language>ja</language>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<item>
		<title>[医学] 腫瘍に行って癌治療薬3つを生み出すようにした大腸菌が固形癌マウスに有効</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110684&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110684&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 17 Sep 2026 16:44:50 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110684&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 涙のセロトニン量を繰り返し測定しうるコンタクトレンズを開発〜無線化が必要</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110683&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110683&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 17 Sep 2026 16:18:42 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110683&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] BioMarinがC型ナトリウム利尿ペプチド薬Voxzogoのヌーナン症候群開発中止</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110682&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110682&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 中止 || 開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 17 Sep 2026 14:21:31 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110682&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] NovartisのTREM2活性化薬VHB937の筋萎縮性側索硬化症（ALS）Ph2試験失敗</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110681&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110681&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 17 Sep 2026 12:52:00 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110681&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 中枢や末梢の神経系に核酸を届ける治療薬にLillyがQurCan社と協力して取り組む</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110680&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110680&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 17 Sep 2026 12:09:21 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110680&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Vera社のBAFFとAPRILの阻害薬TrutaknaでIgA腎症患者の腎機能が安定化した</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110679&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110679&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 17 Sep 2026 11:38:28 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110679&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Lillyの肥満薬LY4064912のPh1試験中止</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110678&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110678&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第1相試験 || 開発 / 臨床試験 / 中止</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 17 Sep 2026 09:52:05 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110678&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] AZ/第一三共のEnhertuの肺癌初治療Ph3試験が死亡数増加の事態に陥っている</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110677&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110677&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 17 Sep 2026 09:39:13 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110677&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Ascendis社のTransCon技術を取り入れた月1回投与GLP-1薬作りをNovo社が断念</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110676&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110676&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 17 Sep 2026 08:43:58 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110676&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 大鵬薬品/Cullinan共同開発のEFGR阻害薬込み肺癌初治療の無増悪生存6か月改善</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110675&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110675&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 17 Sep 2026 08:02:41 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110675&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Novo Nordisk社がNovoを通称にする</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110674&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110674&amp;ref=rss</guid>
		<category>ビジネス / 会社運営 / 新規事業・事業拡大</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 17 Sep 2026 07:19:54 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110674&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 来年Ph1試験に進む3標的T細胞紐づけ薬をGSKがChimagenから手にする</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110673&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110673&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 16 Sep 2026 17:05:01 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110673&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 先立つ治療1回までのTKI未肺癌患者の94%にGSKのROS1阻害薬Jideytroが奏効</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110672&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110672&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 16 Sep 2026 16:27:25 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110672&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] J&amp;Jの抗精神病薬Caplytaで大うつ病患者の性機能が改善</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110671&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110671&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 16 Sep 2026 13:15:35 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110671&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 初治療失敗の小細胞肺癌患者死亡率がGSKのB7-H3標的弾込め抗体で54%低下</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110670&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110670&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 16 Sep 2026 12:23:52 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110670&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 【増補版】2型糖尿病患者の早期スタチン開始で認知症予防</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110669&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110669&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 16 Sep 2026 10:38:33 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110669&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 【増補版】出産時の子宮筋収縮開始の嚆矢が判明したらしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110668&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110668&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 16 Sep 2026 06:41:19 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110668&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Akesoのivonescimab単独肺癌初治療生存が中国Ph3試験でKeytrudaを8か月上回る</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110667&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110667&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 15 Sep 2026 16:35:55 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110667&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] B7H3標的ADCのTam-Peliが小細胞肺癌二番手治療の中国Ph3試験で生存改善達成</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110666&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110666&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 15 Sep 2026 15:13:57 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110666&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 2型糖尿病患者のスタチン使用と認知症を生じ難いことが関連</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110635&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110635&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 15 Sep 2026 13:58:44 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110635&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Definium社の意識変容薬DT120の全般性不安障害Ph3試験第2弾も目標達成</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110665&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110665&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 15 Sep 2026 12:16:34 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110665&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 米国の薬価引き下げMost-favoured-nationの節約は企業との取り引きで損なわれる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110664&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110664&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 15 Sep 2026 10:07:31 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110664&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 2歳未満乳幼児への黄熱病ワクチン17DD小分け投与の抗体生成が標準量に劣らず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110663&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110663&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 15 Sep 2026 08:01:08 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110663&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 胃癌手術前後のAstraZenecaのImfinzi込み治療で全生存が改善したPh3試験論文</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110662&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110662&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 15 Sep 2026 07:11:36 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110662&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 億万長者に課税して富を再分配することで数百〜数千万人を救える</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110661&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110661&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 14 Sep 2026 16:36:52 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110661&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 初期非小細胞肺癌の照射に加えてTecentriqを投与したところで生存改善せず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110660&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110660&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 14 Sep 2026 16:12:07 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110660&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ダウン症候群成人のてんかんがアルツハイマー病発症後に急増</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110659&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110659&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 14 Sep 2026 15:59:11 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110659&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 細菌の溶解物OM-85経口投与の喘鳴下気道疾患予防効果なし</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110658&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110658&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 14 Sep 2026 15:39:00 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110658&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ゴキブリの乳の研究に今年のイグノーベル（Ig Nobel）化学賞が贈られた</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110657&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110657&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 14 Sep 2026 07:28:12 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110657&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 脳の外のリンパ節の樹状細胞がT細胞が活性化させてタウ絡みの神経変性をおこす</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110656&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110656&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 13 Sep 2026 15:17:53 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110656&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] GABA分泌神経が神経膠腫を抑える</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110655&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110655&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 13 Sep 2026 13:14:04 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110655&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] どうやら不用意な薬の上塗り24種が巷の老人に蔓延している</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110654&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110654&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 13 Sep 2026 12:44:21 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110654&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] SLEを生じやすくするIRF7遺伝子変化が一方では抗ウイルス反応を助ける</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110653&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110653&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 13 Sep 2026 10:05:24 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110653&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Scholar Rock社の脊髄性筋萎縮症（SMA）薬Isembyldを米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110652&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110652&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 13 Sep 2026 08:39:50 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110652&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 妊娠初期のアセトアミノフェン使用と赤ちゃんの卵巣や精巣が小さいことが関連</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110651&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110651&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 12 Sep 2026 15:38:26 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110651&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] マクロファージから筋細胞へのミトコンドリア輸出が出産の開始に携わるらしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110650&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110650&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 12 Sep 2026 13:26:24 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110650&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 進行した骨粗鬆症女性の骨折がフコシル化間葉系幹細胞の静注で大幅に減った</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110649&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110649&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 12 Sep 2026 11:46:01 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110649&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] AstraZenecaのエストロゲン受容体分解薬Etcamah乳癌初治療Ph3試験目標未達成</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110648&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110648&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 12 Sep 2026 08:45:48 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110648&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Exelixis社の大腸癌薬zanzalintinib承認申請の米国審査3か月延長</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110647&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110647&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認申請</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 12 Sep 2026 08:27:35 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110647&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Pharming社の活性化PI3Kδ症候群薬Joenjaの幼い小児患者への使用を米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110646&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110646&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 12 Sep 2026 07:30:19 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110646&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 脾臓の様相10種と冠動脈疾患（CAD）が関連</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110645&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110645&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 11 Sep 2026 16:50:29 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110645&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 小さな抗体ナノボディ5つの組み合わせがコブラ毒からマウスを守った</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110644&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110644&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 11 Sep 2026 16:25:36 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110644&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ゲノム配列検査で分からなかった424人中13人の病気診断を血中蛋白質検査で達成</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110643&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110643&amp;ref=rss</guid>
		<category>技術 / 診断 / 全般</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 11 Sep 2026 16:07:47 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110643&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] CD8αβとCD200R-CD28発現MCPyV狙いT細胞がメルケル細胞癌により効きそう</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110642&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110642&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 11 Sep 2026 15:01:23 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110642&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] GLP-1受容体をより発現する遺伝的素因と男性型脱毛を生じ易いことが関連</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110641&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110641&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 11 Sep 2026 14:14:39 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110641&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 韓国SK社にあげる算段のBiohaven社のてんかん薬の試験を米国が部分差し止め</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110640&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110640&amp;ref=rss</guid>
		<category>ビジネス / トラブル / 安全性</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 11 Sep 2026 12:53:55 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110640&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] AbbVieの経口CGRP阻害薬Qulipta/Aquiptaが月経女性の片頭痛日数を減らした</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110639&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110639&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 11 Sep 2026 11:29:56 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110639&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 睡眠中の徐波をピンクノイズで後押しすることで脳脊髄液の流れ促進</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110638&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110638&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 11 Sep 2026 10:05:28 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110638&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] サンドホフ病（SD）遺伝子治療静注が猫に有効</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110637&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110637&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 11 Sep 2026 08:28:58 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110637&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] MMP-9阻害抗体が糖尿病マウスの末梢神経障害を緩和</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110636&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110636&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 11 Sep 2026 07:10:04 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110636&amp;ref=rss</comments>
	</item>
</channel>
</rss>
